Stability: null
Tofacitinib Citrate Intermediate. Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.
More details:View company website
Its Free
Verify Now